A+ R A-

Prognostic Markers Waldenstrom's Macroglobulinemia

Please select from the following list of abstracts, representing presentations given at Athens 2002 (IWWM-2) Session 4:

Prognostic Factors in Waldenstrom's Macroglobulinemia. Merlini G, Baldini L, Broglia C, Goldaniga M, Palladini G, Gobbi PG.

Prognostic Factors in Waldenstrom's Macroglobulinemia: Description of the Complications During the Evolution. Laure Stalnikiewicz, Laurence Detourmignies, Pierre Morel.

Fludarabine for Waldenstrom's Macroglobulinemia: Update of Southwest Oncology Group S9003 trial. Bart Barlogie, Joth Jacobson, Madhav Dhodapkar, Robert Kyle, Morie Gertz, David Roodman, John Crowley.

Patterns of Clinical Presentation, treatment, and Outcome in Patients with Waldenstrom's Macroglobulinemia: a Two Institutional Study. Bjorkholm M, Johansson E, Papamichael D, Celsing F, Matthews J, Lister TA, Rohatiner AZS.

Smouldering Waldenstrom's Macroglobulinemia: Factors Predicting Evolution To Symptomatic Disease. Clara Cesana, Sara Miqueleiz, Patrizia Bernuzzi, Elisabetta Tresoldi, Valentina Rossi, Giovanna Avanzo, Davide Filippini, Enrica Morra.